(1)
Evaluating The Safety Profile Of Nintedanib Among ILD Patients In A Tertiary Care Hospital: A Prospective Research Approach Focusing On Adverse Drug Reactions. Int. J. Environ. Sci. 2025, 5496-5502. https://doi.org/10.64252/69nwp181.